A randomized controlled trial to evaluate the effectiveness of Celecoxib vs placebo as an additional treatment for depression in outpatients of Colombo North Teaching hospital Ragama. - Trial SLCTR_2018_027
Access comprehensive clinical trial information for SLCTR_2018_027 through Pure Global AI's free database. This Phase 4 trial is sponsored by Faculty of Medicine, University of Kelaniya and is currently status unknown. The study focuses on Depression.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
SLCTR_2018_027
Phase 4
Trial Details
Sri Lanka Clinical Trials Registry • SLCTR_2018_027
A randomized controlled trial to evaluate the effectiveness of Celecoxib vs placebo as an additional treatment for depression in outpatients of Colombo North Teaching hospital Ragama.
Celecoxib as adjunctive therapy in depression: a double- blind, randomized controlled trial
Study Focus
Interventional
Sponsor & Location
Faculty of Medicine, University of Kelaniya
Sri Lanka
Timeline & Enrollment
Phase 4
N/A
N/A
ICD-10 Classifications
Depressive episode
Other depressive episodes
Recurrent depressive disorder
Recurrent depressive disorder, unspecified
Post-schizophrenic depression
Data Source
Sri Lanka Clinical Trials Registry
SLCTR_2018_027
Non-Device Trial